» Articles » PMID: 10074145

Human Antibody Responses to Mature and Immature Forms of Viral Envelope in Respiratory Syncytial Virus Infection: Significance for Subunit Vaccines

Overview
Journal J Virol
Date 1999 Mar 12
PMID 10074145
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

A number of antibodies generated during human respiratory syncytial virus (RSV) infection have been cloned by the phage library approach. Antibodies reactive with an immunodominant epitope on the F glycoprotein of this virus have a high affinity for affinity-purified F antigen. These antibodies, however, have a much lower affinity for mature F glycoprotein on the surface of infected cells and are nonneutralizing. In contrast, a potent neutralizing antibody has a high affinity for mature F protein but a much lower affinity for purified F protein or F protein in viral lysates. The data indicate that at least two F protein immunogens are produced during natural RSV infection: immature F, found in viral lysates, and mature F, found on infected cells or virions. Binding studies with polyclonal human immunoglobulin G suggest that the antibody responses to the two immunogens are of similar magnitudes. Competitive binding studies suggest that overlap between the responses is relatively limited. A mature envelope with an antigenic configuration different from that of the immature envelope has an evolutionary advantage in that the infecting virus is less subject to neutralization by the humoral response to the immature envelope that inevitably arises following lysis of infected cells. Subunit vaccines may be at a disadvantage because they most often resemble immature envelope molecules and ignore this aspect of viral evasion.

Citing Articles

Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.

Okba N, Raj V, Widjaja I, GeurtsvanKessel C, de Bruin E, Chandler F Emerg Infect Dis. 2019; 25(10):1868-1877.

PMID: 31423970 PMC: 6759241. DOI: 10.3201/eid2510.190051.


Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.

Liang B, Surman S, Amaro-Carambot E, Kabatova B, Mackow N, Lingemann M J Virol. 2015; 89(18):9499-510.

PMID: 26157122 PMC: 4542370. DOI: 10.1128/JVI.01373-15.


Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics.

Widjaja I, Rigter A, Jacobino S, van Kuppeveld F, Leenhouts K, Palomo C PLoS One. 2015; 10(6):e0130829.

PMID: 26107504 PMC: 4481108. DOI: 10.1371/journal.pone.0130829.


Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present.

Vaughan K, Ponomarenko J, Peters B, Sette A PLoS One. 2015; 10(5):e0127108.

PMID: 26001197 PMC: 4441423. DOI: 10.1371/journal.pone.0127108.


Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.

Cox R, Erickson J, Hastings A, Becker J, Johnson M, Craven R J Virol. 2014; 88(11):6368-79.

PMID: 24672031 PMC: 4093842. DOI: 10.1128/JVI.00332-14.


References
1.
Jonsson U, Fagerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K . Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques. 1991; 11(5):620-7. View

2.
. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998; 102(3 Pt 1):531-7. View

3.
Barbas 3rd C, Crowe Jr J, Cababa D, Jones T, Zebedee S, Murphy B . Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci U S A. 1992; 89(21):10164-8. PMC: 50298. DOI: 10.1073/pnas.89.21.10164. View

4.
Barbas 3rd C, Collet T, AMBERG W, Roben P, Binley J, Hoekstra D . Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J Mol Biol. 1993; 230(3):812-23. DOI: 10.1006/jmbi.1993.1203. View

5.
Williamson R, Burioni R, Sanna P, Partridge L, Barbas 3rd C, Burton D . Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci U S A. 1993; 90(9):4141-5. PMC: 46462. DOI: 10.1073/pnas.90.9.4141. View